A Single Dose of Novel PSMA-Targeting Radiopharmaceutical Agent [ 177 Lu]Ludotadipep for Patients with Metastatic Castration-Resistant Prostate Cancer: Phase I Clinical Trial.
Saved in:
| Title: | A Single Dose of Novel PSMA-Targeting Radiopharmaceutical Agent [ 177 Lu]Ludotadipep for Patients with Metastatic Castration-Resistant Prostate Cancer: Phase I Clinical Trial. |
|---|---|
| Authors: | Shin, Dongho1 (AUTHOR), Ha, Seunggyun2 (AUTHOR), O, Joo Hyun2 (AUTHOR), Rhew, Seung ah1 (AUTHOR), Yoon, Chang Eil1 (AUTHOR), Kwon, Hyeok Jae1 (AUTHOR), Moon, Hyong Woo1 (AUTHOR), Park, Yong Hyun1 (AUTHOR), Park, Sonya Youngju2 (AUTHOR), Park, Chansoo3 (AUTHOR), Chi, Dae Yoon3 (AUTHOR), Yoo, Ie Ryung2 (AUTHOR) iryoo@catholic.ac.kr, Lee, Ji Youl1 (AUTHOR) iryoo@catholic.ac.kr |
| Source: | Cancers. 12/15/2022, Vol. 14 Issue 24, p6225. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers14246225 |
